FDA Approves LENALIDOMIDE — Dr. Reddy's Laboratories Inc.

# FDA Approves Dr. Reddy's Laboratories Generic Lenalidomide Dr. Reddy's Laboratories Inc. received FDA approval for its generic version of lenalidomide (ANDA209348), an oral immunomodulatory agent used to treat multiple myeloma and other hematologic malignancies. The approval is expected to increase market competition and potentially reduce patient costs for this widely prescribed oncology medication.